ODU & Admera Health collaborate on a grant-funded project to build a generative AI platform linking genes to Alzheimer's progression & cognitive decline.

Admera Health earns CAP re-accreditation, reaffirming its excellence in high-quality NGS services and commitment to precision in laboratory operations.

Admera Health supercharges capabilities with a second NovaSeq X Plus! Double the power means double the speed for delivering high-throughput projects, large or small.

Admera Health announces six winners of their Stereo-seq grant program in partnership with Complete Genomics to accelerate spatial transcriptomics studies.

Admera Health and Twist Bioscience collaborate to expand Next-Generation-Sequencing service offerings as a certified provider through the NGS Prolab program.

Admera Health achieves Certified Service Provider status for Parse Biosciences Evercode™ Whole Transcriptome technologies to expand access to scalable, high-quality single-cell analysis.

Admera Health introduces a clinical-grade WGS service to its suite of genomics offerings to advance research with an added layer of confidence.

Admera Health announces the seven winners of their single-cell sequencing grant program powered by 10x Genomics technology.

Admera Health acquires BioEcho, boosting its NGS services with DNA/RNA extraction tech, expanding global presence and research capabilities.

Singleron Biotechnologies and Admera Health announced their strategic alliance at this year’s Festical of Genomics and Biodata in Boston, marking a significant step towards further empowering academic and pharmaceutical researchers across the United States.